ArticleInvestigational new drugs2012

Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells.

David Davidson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.